학술논문
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Document Type
Article
Author
Spring, L.M.; Tolaney, S.M.; Fell, G.; Bossuyt, V.; Abelman, R.O.; Wu, B.; Maheswaran, S.; Trippa, L.; Comander, A.; Mulvey, T.; McLaughlin, S.; Ryan, P.; Ryan, L.; Abraham, E.; Rosenstock, A.; Garrido-Castro, A.C.; Lynce, F.; Moy, B.; Isakoff, S.J.; Tung, N.; Mittendorf, E.A.; Ellisen, L.W.; Bardia, A.
Source
In Annals of Oncology March 2024 35(3):293-301
Subject
Language
ISSN
0923-7534